Bulk Manufacturer of Controlled Substances Application: Stepan Company, 10466 [2020-03618]
Download as PDF
<![CDATA[
10466
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
Controlled substance
Drug code
Alphamethadol .................................................................................................................................................................
Benzethidine ....................................................................................................................................................................
Betacetylmethadol ...........................................................................................................................................................
Clonitazene ......................................................................................................................................................................
Diampromide ...................................................................................................................................................................
Diethylthiambutene ..........................................................................................................................................................
Dimethylthiambutene .......................................................................................................................................................
Ketobemidone ..................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ......................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ..............................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tilidine .............................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
Para-Fluorofentanyl .........................................................................................................................................................
3-Methylfentanyl ..............................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl-alpha-methylfentanyl .............................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Beta-hydroxyfentanyl .......................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ........................................................................................................................................
Alpha-methylthiofentanyl .................................................................................................................................................
3-Methylthiofentanyl .........................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .............................................................
Thiofentanyl .....................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..........................................................................
Cyclopropyl Fentanyl .......................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ...................................................................................
Morrissette Drive, Springfield, Virginia
22152.
The company plans to manufacture
the above-listed controlled substances
as analytical reference standards for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 18, 2019,
Stepan Company, 100 West Hunter
Avenue, Maywood, New Jersey 07607–
1021 applied to be registered as a bulk
manufacturer of the following basic
class of controlled substances:
SUPPLEMENTARY INFORMATION:
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–03616 Filed 2–21–20; 8:45 am]
BILLING CODE 4410–09–P
Drug
code
Controlled substance
DEPARTMENT OF JUSTICE
Cocaine ........................
Ecgonine .......................
Drug Enforcement Administration
[Docket No. DEA–580]
lotter on DSKBCFDHB2PROD with NOTICES
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 24, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
I
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
Bulk Manufacturer of Controlled
Substances Application: Stepan
Company
ACTION:
I
9041
9180
Schedule
[FR Doc. 2020–03618 Filed 2–21–20; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
9605
9606
9607
9612
9615
9616
9619
9628
9648
9661
9663
9737
9739
9740
9743
9750
9780
9801
9812
9813
9814
9815
9821
9830
9831
9832
9833
9834
9835
9843
9845
9850
Schedule
I
I
I
I
I
I
I
I
II
I
I
II
II
II
II
I
II
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–586]
Importer of Controlled Substances
Application: Research Triangle
Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 25, 2020. Such persons
may also file a written request for a
hearing on the application on or before
March 25, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
DATES:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Page 10466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03618]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-580]
Bulk Manufacturer of Controlled Substances Application: Stepan
Company
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 24, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on December 18, 2019, Stepan Company, 100 West Hunter
Avenue, Maywood, New Jersey 07607-1021 applied to be registered as a
bulk manufacturer of the following basic class of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cocaine................................ 9041 II
Ecgonine............................... 9180 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for distribution to its customers.
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03618 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P
